| Related Articles |
StatPearls
Book. 2018 01
Authors:
Abstract
Methamphetamine (METH) belongs to a class of compounds called phenethylamines which exhibits catecholaminergic, dopaminergic, and serotonergic effects. It was first manufactured in 1893 for the treatment of asthma and upper respiratory congestion, but indications and usage in the medical field have increased over the last 124 years. Today, methamphetamines are clinically used for the treatment of short-term obesity, narcolepsy, and attention deficit disorder with hyperactivity. Recreational use of methamphetamines has reached epidemic proportions in the South Pacific (Asia, Japan, China, Philippines), as well as the United States. The majority of illegal methamphetamines are produced in the United States in rural areas in what is known as clandestine labs. Using common household materials, including, acetone, red phosphorus, sodium hydroxide, sulfuric acid, ammonia, toluene, along with over the counter cold medicines, ephedrine and pseudoephedrine, methamphetamines can be easily manufactured. The routes of methamphetamine administration may be inhalation, intravenous, intramuscular, or transmucosal (oral/nasal). Peak plasma levels can range from 5 to 10 minutes via intravenous administration, and up to 2 to 3 hours if taken transmucosally. Symptoms typically last hours to days, based on dosage and strength, and dissipate once the drug is eliminated from the body. Given the acute symptoms are seen with intoxication, it is difficult for the clinician to distinguish methamphetamine-associated psychosis from the acute psychosis of a primary mental disorder. Most agree that psychosis following the use of methamphetamines is characterized by persecutory delusions, visual hallucinations, and symptoms resembling acute psychosis, most likely schizophrenia. There is also a clear pattern of high dosage and daily usage correlating with higher risks of substance-induced psychosis. Methamphetamines impair the cognitive thought process and subsequently precede acute psychosis. This suggests that continued impairment due to methamphetamine use is a precursor to psychosis.
PMID: 29493990
via https://www.ncbi.nlm.nih.gov/pubmed/29493990?dopt=Abstract
